Hospital
Katherine Shaw Bethea Hospital
Katherine Shaw Bethea Hospital was paid $991K by Medicaid between Jan 2018 and Jun 2020, across 97 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 46% of everything it billed.
33Billing provider infoKATHERINE SHAW BETHEA HOSPITAL
DIXON, IL 61021
DIXON, IL 61021
33aNPI1427043546assigned 09/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$991K
24GClaims41,951
24DCodes billed97
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#49 of 129
Median peer was paid$547K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,881 | $300K | |
| 2019 | 21,772 | $525K | |
| 2020 | 7,298 | $167K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 46% | 6,603 | 1,579 | $453K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 9.0% | 2,285 | 595 | $89K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 8.7% | 2,489 | 518 | $86K |
| 97162 | 8.1% | 758 | 453 | $80K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.4% | 491 | 444 | $33K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 823 | 766 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 2,106 | 1,942 | $26K |
| 87631 | 2.1% | 222 | 203 | $21K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.8% | 702 | 632 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 703 | 632 | $17K |
| 80053 | Comprehensive metabolic panel | 1.6% | 2,640 | 2,420 | $16K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 304 | 259 | $14K |
85 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,114 | $8K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 156 | $6K |
| 73630 | <1% | 494 | $6K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 90 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 948 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 224 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 748 | $5K |
| 87581 | <1% | 141 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,312 | $4K |
| 80061 | Lipid panel | <1% | 1,587 | $4K |
| 83655 | <1% | 426 | $4K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 181 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 415 | $4K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 215 | $3K |
| 81001 | <1% | 1,827 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 741 | $3K |
| 87450 | <1% | 657 | $3K | |
| 84439 | <1% | 882 | $3K | |
| 84702 | <1% | 352 | $2K | |
| 73562 | <1% | 166 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 234 | $2K |
| 80081 | <1% | 27 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 34 | $1K |
| 88142 | <1% | 630 | $1K | |
| 82607 | <1% | 188 | $1K | |
| 82728 | <1% | 492 | $1K | |
| 83550 | <1% | 339 | $1K | |
| 87653 | <1% | 33 | $1K | |
| 85610 | <1% | 379 | $1K | |
| 83540 | <1% | 443 | $970.46 | |
| 80076 | <1% | 136 | $824.62 | |
| 87186 | <1% | 66 | $670.39 | |
| 73610 | <1% | 39 | $670.32 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 67 | $646.79 |
| 87210 | <1% | 377 | $637.03 | |
| 73110 | <1% | 33 | $572.40 | |
| 74018 | <1% | 70 | $536.36 | |
| 86003 | <1% | 28 | $509.14 | |
| 92567 | <1% | 29 | $428.91 | |
| 84466 | <1% | 99 | $401.39 | |
| 87807 | <1% | 73 | $382.89 | |
| 81025 | <1% | 206 | $356.86 | |
| 84703 | <1% | 66 | $292.74 | |
| 85018 | <1% | 265 | $289.46 | |
| 85014 | <1% | 263 | $278.04 | |
| 84460 | <1% | 71 | $272.16 | |
| 72100 | <1% | 13 | $181.49 | |
| 82950 | <1% | 55 | $176.70 | |
| 85652 | <1% | 150 | $135.15 | |
| 84450 | <1% | 70 | $126.88 | |
| 86592 | <1% | 82 | $124.50 | |
| 80055 | <1% | 15 | $122.30 | |
| 82374 | <1% | 54 | $121.42 | |
| 87220 | <1% | 43 | $114.26 | |
| 82435 | <1% | 53 | $113.88 | |
| 84075 | <1% | 54 | $112.24 | |
| 84132 | <1% | 58 | $109.50 | |
| 82565 | <1% | 58 | $108.72 | |
| 82247 | <1% | 55 | $108.72 | |
| 84295 | <1% | 55 | $104.19 | |
| 85027 | <1% | 54 | $101.07 | |
| 82310 | <1% | 53 | $99.66 | |
| 82040 | <1% | 54 | $96.36 | |
| 84155 | <1% | 58 | $94.50 | |
| 82947 | <1% | 62 | $93.00 | |
| 84520 | <1% | 59 | $86.91 | |
| 85651 | <1% | 37 | $85.12 | |
| 97014 | <1% | 35 | $75.84 | |
| 81015 | <1% | 152 | $73.95 | |
| 82746 | <1% | 14 | $66.90 | |
| 82784 | <1% | 12 | $61.83 | |
| 84481 | <1% | 12 | $59.10 | |
| 83718 | <1% | 12 | $46.80 | |
| 82785 | <1% | 15 | $41.82 | |
| 80050 | General health panel | <1% | 13 | $31.95 |
| 87070 | <1% | 13 | $30.15 | |
| 84478 | <1% | 12 | $26.25 | |
| 83516 | <1% | 12 | $25.62 | |
| 81003 | <1% | 13 | $21.21 | |
| 82465 | <1% | 12 | $20.65 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 690 | $7.98 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 61 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 22 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 148 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRAZIER, AUSTIN (CFO)